[ad_1]
Treatment patterns in patients with castration-resistant prostate cancer who received darolutamide in the ARAMIS trial in Spain: PARASEC study springermedicine.com
[ad_2]
Related Posts
Meet Dr Happi. With $100m and a steely determination could he save the world from the next pandemic? | Global health
[ad_1] Winning the world’s health lottery is a lonely business in the current climate. “It’s like being an orphan in a space where there used […]
AI tool predicts heart failure up to five years before symptoms appear
[ad_1] Image: © magicmine | iStock An AI tool developed by Oxford researchers can predict a person’s risk of heart failure up to five years […]
ow Dose Lithium Treatment in MCI
[ad_1] LITHIUM treatment may modestly slow memory decline in older adults with mild cognitive impairment, according to pilot trial findings that provide early effect size estimates. […]